Cardiac Optogenetics: 2018

Deisseroth, 2006, Next-generation optical technologies for illuminating genetically targeted brain circuits, J Neurosci, 26, 10380, 10.1523/JNEUROSCI.3863-06.2006 Nagel, 2002, Channelrhodopsin-1: a light-gated proton channel in green algae, Science, 296, 2395, 10.1126/science.1072068 Nagel, 2003, Channelrhodopsin-2, a directly light-gated cation-selective membrane channel, Proc Natl Acad Sci U S A, 100, 13940, 10.1073/pnas.1936192100 Boyden, 2005, Millisecond-timescale, genetically targeted optical control of neural activity, Nat Neurosci, 8, 1263, 10.1038/nn1525 Li, 2005, Fast noninvasive activation and inhibition of neural and network activity by vertebrate rhodopsin and green algae channelrhodopsin, Proc Natl Acad Sci U S A, 102, 17816, 10.1073/pnas.0509030102 Nagel, 2005, Channelrhodopsins: directly light-gated cation channels, Biochem Soc Trans, 33, 863, 10.1042/BST0330863 2011, Method of the year 2010, Nat Meth, 8, 1, 10.1038/nmeth.f.321 Bruegmann, 2010, Optogenetic control of heart muscle in vitro and in vivo, Nat Methods, 7, 897, 10.1038/nmeth.1512 Arrenberg, 2010, Optogenetic control of cardiac function, Science, 330, 971, 10.1126/science.1195929 Jia, 2011, Stimulating cardiac muscle by light: cardiac optogenetics by cell delivery, Circ Arrhythm Electrophysiol, 4, 753, 10.1161/CIRCEP.111.964247 Abilez, 2011, Multiscale computational models for optogenetic control of cardiac function, Biophys J, 101, 1326, 10.1016/j.bpj.2011.08.004 Boyle, 2013, A comprehensive multiscale framework for simulating optogenetics in the heart, Nat Commun, 4, 2370, 10.1038/ncomms3370 Entcheva, 2013, Cardiac optogenetics, Am J Physiol Heart Circ Physiol, 304, H1179, 10.1152/ajpheart.00432.2012 Quinn, 2016, Electrotonic coupling of excitable and nonexcitable cells in the heart revealed by optogenetics, Proc Natl Acad Sci U S A, 113, 14852, 10.1073/pnas.1611184114 Yu, 2017, OptoGap: an optogenetics-enabled assay for quantification of cell-cell coupling in multicellular cardiac tissue, bioRxiv Zhou, 2008, Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart, Nature, 454, 109, 10.1038/nature07060 Koopman, 2017, Cardiac optogenetics: using light to monitor cardiac physiology, Basic Res Cardiol, 112, 56, 10.1007/s00395-017-0645-y Nagel, 2005, Light activation of channelrhodopsin-2 in excitable cells of Caenorhabditis elegans triggers rapid behavioral responses, Curr Biol, 15, 2279, 10.1016/j.cub.2005.11.032 Kleinlogel, 2011, Ultra light-sensitive and fast neuronal activation with the Ca(2)+-permeable channelrhodopsin CatCh, Nat Neurosci, 14, 513, 10.1038/nn.2776 Dawydow, 2014, Channelrhodopsin-2-XXL, a powerful optogenetic tool for low-light applications, Proc Natl Acad Sci U S A, 111, 13972, 10.1073/pnas.1408269111 Lin, 2013, ReaChR: a red-shifted variant of channelrhodopsin enables deep transcranial optogenetic excitation, Nat Neurosci, 16, 1499, 10.1038/nn.3502 Park, 2014, Optical mapping of optogenetically shaped cardiac action potentials, Sci Rep, 4, 6125, 10.1038/srep06125 Govorunova, 2016, Anion channelrhodopsins for inhibitory cardiac optogenetics, Sci Rep, 6, 33530, 10.1038/srep33530 Vogt, 2015, Systemic gene transfer enables optogenetic pacing of mouse hearts, Cardiovasc Res, 106, 338, 10.1093/cvr/cvv004 Nyns, 2017, Optogenetic termination of ventricular arrhythmias in the whole heart: towards biological cardiac rhythm management, Eur Heart J, 38, 2132 Bruegmann, 2016, Optogenetic defibrillation terminates ventricular arrhythmia in mouse hearts and human simulations, J Clin Invest, 126, 3894, 10.1172/JCI88950 Ambrosi, 2017, Adeno-associated virus mediated gene delivery: Implications for scalable in vitro and in vivo cardiac optogenetic models, bioRxiv Zaglia, 2015, Optogenetic determination of the myocardial requirements for extrasystoles by cell type-specific targeting of ChannelRhodopsin-2, Proc Natl Acad Sci U S A, 112, E4495, 10.1073/pnas.1509380112 Wang, 2017, Optogenetic Control of Heart Rhythm by Selective Stimulation of Cardiomyocytes Derived from Pnmt+ Cells in Murine Heart, Sci Rep, 7, 40687, 10.1038/srep40687 Hulsmans, 2017, Macrophages facilitate electrical conduction in the heart, Cell, 169, 510, 10.1016/j.cell.2017.03.050 Yu, 2015, Cardiac Optogenetics: Enhancement by All-trans-Retinal, Sci Rep, 5, 16542, 10.1038/srep16542 Greenberg, 2016, Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial, Lancet, 387, 1178, 10.1016/S0140-6736(16)00082-9 Hajjar, 2017, Introducing Genes to the Heart: All About Delivery, Circ Res, 120, 33, 10.1161/CIRCRESAHA.116.310039 Greenberg, 2017, Gene therapy for heart failure, Trends Cardiovasc Med, 27, 216, 10.1016/j.tcm.2016.11.001 Sugano, 2011, Immune responses to adeno-associated virus type 2 encoding channelrhodopsin-2 in a genetically blind rat model for gene therapy, Gene Ther, 18, 266, 10.1038/gt.2010.140 Perny, 2016, Chronic activation of the D156A point mutant of Channelrhodopsin-2 signals apoptotic cell death: the good and the bad, Cell Death Dis, 7, 10.1038/cddis.2016.351 Li, 2017, Electrophysiological Properties and Viability of Neonatal Rat Ventricular Myocyte Cultures with Inducible ChR2 Expression, Sci Rep, 7, 1531, 10.1038/s41598-017-01723-2 Yu, 2016, Inscribing Optical Excitability to Non-Excitable Cardiac Cells: Viral Delivery of Optogenetic Tools in Primary Cardiac Fibroblasts, Methods Mol Biol, 1408, 303, 10.1007/978-1-4939-3512-3_21 Boyle, 2015, “Beauty is a light in the heart”: the transformative potential of optogenetics for clinical applications in cardiovascular medicine, Trends Cardiovasc Med, 25, 73, 10.1016/j.tcm.2014.10.004 Berry, 2015, X-optogenetics and U-optogenetics: feasibility and possibilities, Photonics, 2, 23, 10.3390/photonics2010023 Huang, 2016, Nanomaterial mediated optogenetics: opportunities and challenges, RSC Advances, 6, 60896, 10.1039/C6RA11289G Boyle, 2015, Computational modeling of cardiac optogenetics: methodology overview & review of findings from simulations, Comput Biol Med, 65, 200, 10.1016/j.compbiomed.2015.04.036 Williams, 2013, Computational optogenetics: empirically derived voltage- and light-sensitive channelrhodopsin-2 model, PLoS Comput Biol, 9, 10.1371/journal.pcbi.1003220 Klimas, 2016, OptoDyCE as an automated system for high-throughput all-optical dynamic cardiac electrophysiology, Nat Commun, 7, 11542, 10.1038/ncomms11542 Colatsky, 2016, The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative - Update on progress, J Pharmacol Toxicol Methods, 81, 15, 10.1016/j.vascn.2016.06.002 Dempsey, 2016, Cardiotoxicity screening with simultaneous optogenetic pacing, voltage imaging and calcium imaging, J Pharmacol Toxicol Methods, 81, 240, 10.1016/j.vascn.2016.05.003 Lapp, 2017, Frequency-dependent drug screening using optogenetic stimulation of human iPSC-derived cardiomyocytes, Sci Rep, 7, 9629, 10.1038/s41598-017-09760-7 Ambrosi, 2015, Optogenetics-enabled assessment of viral gene and cell therapy for restoration of cardiac excitability, Sci Rep, 5, 17350, 10.1038/srep17350 Burton, 2015, Optical control of excitation waves in cardiac tissue, Nat Photonics, 9, 813, 10.1038/nphoton.2015.196 Feola, 2017, Localized optogenetic targeting of rotors in atrial cardiomyocyte monolayers, Circ Arrhythm Electrophysiol, 10, e005591, 10.1161/CIRCEP.117.005591 Bingen, 2014, Light-induced termination of spiral wave arrhythmias by optogenetic engineering of atrial cardiomyocytes, Cardiovasc Res, 104, 194, 10.1093/cvr/cvu179 Watanabe, 2017, Optogenetic manipulation of anatomical re-entry by light-guided generation of a reversible local conduction block, Cardiovasc Res, 113, 354, 10.1093/cvr/cvx003 Xie, 2010, So little source, so much sink: requirements for afterdepolarizations to propagate in tissue, Biophys J, 99, 1408, 10.1016/j.bpj.2010.06.042 Crocini, 2017, Optogenetics gets to the heart: A guiding light beyond defibrillation, Prog Biophys Mol Biol, 130, 132, 10.1016/j.pbiomolbio.2017.05.002 Nussinovitch, 2015, Optogenetics for in vivo cardiac pacing and resynchronization therapies, Nat Biotechnol, 33, 750, 10.1038/nbt.3268 Epstein, 2013, 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities, J Am Coll Cardiol, 61, e6, 10.1016/j.jacc.2012.11.007 Sharma, 2015, Permanent His-bundle pacing is feasible, safe, and superior to right ventricular pacing in routine clinical practice, Heart Rhythm, 12, 305, 10.1016/j.hrthm.2014.10.021 Karathanos, 2016, Opsin spectral sensitivity determines the effectiveness of optogenetic termination of ventricular fibrillation in the human heart: a simulation study, J Physiol, 594, 6879, 10.1113/JP271739 Inagaki, 2014, Optogenetic control of Drosophila using a red-shifted channelrhodopsin reveals experience-dependent influences on courtship, Nat Methods, 11, 325, 10.1038/nmeth.2765 Sengupta, 2016, Red-shifted channelrhodopsin stimulation restores light responses in blind mice, macaque retina, and human retina, EMBO Mol Med, 8, 1248, 10.15252/emmm.201505699 Crocini, 2016, Optogenetics design of mechanistically based stimulation patterns for cardiac defibrillation, Sci Rep, 6, 35628, 10.1038/srep35628 Boyle, 2018, Termination of reentrant atrial tachycardia via optogenetic stimulation with optimized spatial targeting: insights from computational models, J Physiol, 596, 181, 10.1113/JP275264 Zahid, 2016, Feasibility of using patient-specific models and the “minimum cut” algorithm to predict optimal ablation targets for left atrial flutter, Heart Rhythm, 13, 1687, 10.1016/j.hrthm.2016.04.009 Karathanos, 2014, Optogenetics-enabled dynamic modulation of action potential duration in atrial tissue: feasibility of a novel therapeutic approach, Europace, 16 Suppl 4, iv69, 10.1093/europace/euu250